Reverse redistribution of 99mtc-sestamibi after direct percutaneous transluminal coronary angioplasty in acute myocardial infarction: Relationship with wall motion and functional response to dobutamine stimulation

Nuclear Medicine Communications

Volumn 22, Issue 11, 2001, Pages 1223-1230

  Fujiwara, S ^a   Takeishi, Y ^a   Hirono, O ^a   Fukui, A ^a   Okuyama, M ^a   Yamaguchi, S ^a   Ito, M ^a   Kaneko, K ^a   Shishido, T ^a   Miyamoto, T ^a   Yuki, K ^a   Miyashita, T ^a   Takahashi, K ^a   Minamihaba, O ^a   Tomoike, H ^a   Yamauchi, S ^a   Fatema, K ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

99mTc sestamibi; Dobutamine; Echocardiography; Myocardial viability

Indexed keywords

DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DRUG UPTAKE; ECHOCARDIOGRAPHY; FEMALE; HEART MUSCLE PERFUSION; HUMAN; IMAGE ANALYSIS; MALE; MITOCHONDRIAL MEMBRANE; MYOCARDIAL HIBERNATION; REVASCULARIZATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY VESSELS; DOBUTAMINE; ECHOCARDIOGRAPHY; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 0034763799     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200111000-00009     Document Type: Review

References (29)

1. Maddahi J, Berman DS. Reverse redistribution of thallium-201. J Nucl Med 1995; 36: 1019-1021.
2. Arrighi JA, Soufer R. Reverse redistribution: is it clinically relevant or a washout? J Nucl Cardiol 1998; 5: 195-201.
3. Hecht HS, Hopkins JM, Rose JG, Blumfield DE, Wong M. Reverse redistribution: worsening of thallium-201 myocardial images from exercise to redistribution. Radiology 1981; 140: 177-180.
4. Weiss AT, Maddahi J, Lew AS, et al. Reverse redistribution of thallium-201: a sign of nontransmural myocardial infarction with patency of the infarct-related coronary artery. J Am Coll Cardiol 1986; 7: 61-67.
5. Faraggi M, Karila-Cohen D, Brochet E, et al. Relationship between resting Tl-201 reverse redistribution, microvascular perfusion, and functional recovery in acute myocardial infarction. J Nucl Med 2000; 41: 393-399.
6. Pace L, Perrone-Filardi P, Mainenti PP, et al. Effects of myocardial revascularization on regional thallium-201 uptake and systolic function in regions with reverse redistribution on tomographic thallium-201 imaging at rest in patients with chronic coronary artery disease. J Nucl Cardiol 1998; 5: 153-160.
7. Takeishi Y, Sukekawa H, Fujiwara S, Ikeno E, Sasaki Y, Tomoike H. Reverse redistribution of technetium-99m-sestamibi following direct PTCA in acute myocardial infarction. J Nucl Med 1996; 37: 1289-1294.
8. Fujiwara S, Takeishi Y, Atsumi H, et al. Prediction of functional recovery in acute myocardial infarction: comparison between sestamibi reverse redistribution and sestamibi/BMIPP mismatch. J Nucl Cardiol 1998; 5: 119-127.
9. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994; 23: 617-626.
10. Perrone-Filardi P, Pace L, Prastaro M, et al. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995; 91: 2556-2565.
11. Chapman CB, Baker O, Reynolds J, Bonte FJ. Use of biplane cinefluorography for measurement of ventricular volume. Circulation 1958; 18: 1105-1117.
12. Takeishi Y, Fujiwara S, Atsumi H, Takahashi K, Sukekawa K, Tomoike H. Iodine-123-BMIPP imaging in unstable angina: a guide for interventional strategy. J Nucl Med 1997; 38: 1407-1411.
13. Takeishi Y, Takahashi N, Fujiwara S, Atsumi H, Takahashi K, Tomoike H. Myocardial tomography with technetium-99m-tetrofosmin during intravenous infusion of adenosine triphosphate. J Nucl Med 1998; 39: 582-586.
14. Fujiwara S, Takeishi Y, Tojo T, et al. Fatty acid imaging with I-123-15-(p-iodophenyl)-9-R, S-methylpentadecanoic acid in acute coronary syndrome. J Nucl Med 1999; 40: 1999-2006.
15. Jun T, Hirono O, Kubota I, et al. Dobutamine stress echocardiography for the diagnosis of myocardial viability. Jpn Heart J 2000; 41: 435-443.
16. Marin-Neto JA, Marzullo P, Marcassa C, et al. Myocardial perfusion abnormalities in chronic Chagas’ disease as detected by thallium-201 scintigraphy. Am J Cardiol 1992; 69: 780-784.
17. Fragasso G, Rossetti E, Dosio F, et al. High prevalence of the thallium-201 reverse redistribution phenomenon in patients with syndrome X. Eur Heart J 1996; 17: 1482-1487.
18. Tsai CH, Lee JK, Kao CH, Chang JS, Shih WJ. Kawasaki disease evaluated by two dimensional echocardiogram and dipyridamole Tl-201 chloride myocardial SPET. Nucl Med Commun 1997; 18: 412-418.
19. Nii T, Nakashima Y, Nomoto J, Hiroki T, Ohshima F, Arakawa K. Normalization of reverse redistribution of thallium-201 with procainamide pretreatment in Wolff-Parkinson-White syndrome. Clin Cardiol 1991; 14: 269-272.
20. Wacker FJTh, Gibbons RJ, Verani MS, et al. Serial quantitative planer technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy. J Am Coll Cardiol 1989; 14: 861-873.
21. Gibbons RJ, Verani MS, Behrenbeck T, et al. Feasibility of tomographic Tc-99m hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 1989; 80: 1277-1286.
22. Berman DS, Kiat H, Van Train KF, Friedman J, Garcia EV, Maddahi J. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability. Am J Cardiol 1990; 66: 72E-79E.
23. Beller GA, Watson DD. Physiological basis of myocardial perfusion imaging with the technetium 99m agents. Semin Nucl Med 1991; 21: 173-181.
24. Piwnica-Worms D, Kronauge FJ, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium (I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence. Circulation 1990; 82: 1826-1883.
25. Okada RD, Glover D, Gaffney T, Williams S. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 1988; 77: 491-498.
26. Li Q-S, Solot G, Frank TL, Wagner Jr HN, Becker LC. Myocardial redistribution of technetium-99m-methoxyisobutyl isonitrile (SESTAMIBI). J Nucl Med 1990; 31: 1069-1076.
27. Dilsizian V, Arrighi JA, Diodati JG, et al. Myocardial viability in patients with chronic coronary artery disease: comparison of Tc-99m sestamibi with thallium reinjection and [F-18]fluorodeoxyglucose. Circulation 1994; 89: 578-587.
28. Sinusas AJ, Bergin JD, Edwards NC, et al. Redistribution of Tc-99m sestamibi and Tl-201 in the presence of a severe coronary artery stenosis. Circulation 1994; 89: 2332-2341.
29. Beller GA, Glover DK, Edwards NC, Ruiz M, Simanis JP, Watson DD. Tc-99m sestamibi uptake and retention during myocardial ischemia and reperfusion. Circulation 1993; 87: 2033-2042.